|
Name |
Dicernadrol C
|
Molecular Formula | C38H38O16 | |
IUPAC Name* |
[4-acetyloxy-7-[5-acetyloxy-10a-(acetyloxymethyl)-1,8-dihydroxy-6-methyl-9-oxo-6,7-dihydro-5H-xanthen-2-yl]-1,8-dihydroxy-3-methyl-9-oxo-3,4-dihydro-2H-xanthen-4a-yl]methylacetate
|
|
SMILES |
CC(=O)OCC12Oc3ccc(-c4ccc5c(c4O)C(=O)C4=C(O)CC(C)C(OC(C)=O)C4(COC(C)=O)O5)c(O)c3C(=O)C1=C(O)CC(C)C2OC(C)=O
|
|
InChI |
InChI=1S/C38H38O16/c1-15-11-23(43)29-33(47)27-25(53-37(29,13-49-17(3)39)35(15)51-19(5)41)9-7-21(31(27)45)22-8-10-26-28(32(22)46)34(48)30-24(44)12-16(2)36(52-20(6)42)38(30,54-26)14-50-18(4)40/h7-10,15-16,35-36,43-46H,11-14H2,1-6H3/t15-,16-,35-,36-,37+,38+/m0/s1
|
|
InChIKey |
LYWOIRXBEDUAPM-CMDKCIDSSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 750.71 | ALogp: | 4.1 |
HBD: | 4 | HBA: | 16 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 238.7 | Aromatic Rings: | 6 |
Heavy Atoms: | 54 | QED Weighted: | 0.222 |
Caco-2 Permeability: | -5.293 | MDCK Permeability: | 0.00005370 |
Pgp-inhibitor: | 0.972 | Pgp-substrate: | 0.869 |
Human Intestinal Absorption (HIA): | 0.889 | 20% Bioavailability (F20%): | 0.067 |
30% Bioavailability (F30%): | 0.541 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 82.17% |
Volume Distribution (VD): | 0.405 | Fu: | 18.19% |
CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.036 |
CYP2C19-inhibitor: | 0.035 | CYP2C19-substrate: | 0.061 |
CYP2C9-inhibitor: | 0.12 | CYP2C9-substrate: | 0.24 |
CYP2D6-inhibitor: | 0.187 | CYP2D6-substrate: | 0.096 |
CYP3A4-inhibitor: | 0.576 | CYP3A4-substrate: | 0.286 |
Clearance (CL): | 1.18 | Half-life (T1/2): | 0.024 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.968 |
Drug-inuced Liver Injury (DILI): | 0.969 | AMES Toxicity: | 0.021 |
Rat Oral Acute Toxicity: | 0.999 | Maximum Recommended Daily Dose: | 0.085 |
Skin Sensitization: | 0.023 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.017 |
Respiratory Toxicity: | 0.043 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002105 | 0.825 | D07IPB | 0.268 | ||||
ENC005075 | 0.802 | D0T5XN | 0.258 | ||||
ENC001969 | 0.749 | D01XDL | 0.258 | ||||
ENC001973 | 0.721 | D01XWG | 0.258 | ||||
ENC005074 | 0.701 | D0Q0PR | 0.256 | ||||
ENC001968 | 0.678 | D07VLY | 0.248 | ||||
ENC005070 | 0.665 | D0C9XJ | 0.248 | ||||
ENC002870 | 0.651 | D0FX2Q | 0.246 | ||||
ENC001991 | 0.624 | D01UBX | 0.245 | ||||
ENC002978 | 0.587 | D0N1FS | 0.244 |